Skip to Content
You are currently on the new version of our website. Access the old version .
  • Article
  • Open Access

13 February 2021

11 Pages

Arsenoplatin-Ferritin Nanocage: Structure and Cytotoxicity

,
,
,
,
,
and
1
Department of Chemistry “Ugo Schiff”, University of Florence, Via Della Lastruccia, 3-13, Sesto Fiorentino, 50019 Florence, Italy
2
Department of Chemistry and Industrial Chemistry, University of Pisa, Via Giuseppe Moruzzi 13, 56124 Pisa, Italy
3
Department of Chemical Sciences, University of Naples Federico II, Via Cinthia 21, 80126 Naples, Italy
*
Author to whom correspondence should be addressed.

Abstract

Arsenoplatin-1 (AP-1), the prototype of a novel class of metallodrugs containing a PtAs(OH)2 core, was encapsulated within the apoferritin (AFt) nanocage. UV-Vis absorption spectroscopy and inductively coupled plasma-atomic emission spectroscopy measurements confirmed metallodrug encapsulation and allowed us to determine the average amount of AP-1 trapped inside the cage. The X-ray structure of AP-1-encapsulated AFt was solved at 1.50 Å. Diffraction data revealed that an AP-1 fragment coordinates the side chain of a His residue. The biological activity of AP-1-loaded AFt was comparatively tested on a few representative cancer and non-cancer cell lines. Even though the presence of the cage reduces the overall cytotoxicity of AP-1, it improves its selectivity towards cancer cells.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.